dc.contributor.author | Besada, Emilio | |
dc.contributor.author | Nossent, Johannes C | |
dc.date.accessioned | 2014-09-10T10:58:27Z | |
dc.date.available | 2014-09-10T10:58:27Z | |
dc.date.issued | 2012 | |
dc.description.abstract | CRP is a marker of inflammation and is also a known cardiovascular risk factor. Patients with systemic lupus erythematosus (SLE) have moderately elevated CRP levels and develop organ damage , that includes an increased rate of cardiovascular events. | en |
dc.identifier.citation | Scandinavian Journal of Rheumatology 41(2012) s. 60-61 | en |
dc.identifier.cristinID | FRIDAID 1023085 | |
dc.identifier.issn | 0300-9742 | |
dc.identifier.uri | https://hdl.handle.net/10037/6644 | |
dc.identifier.urn | URN:NBN:no-uit_munin_6244 | |
dc.language.iso | eng | en |
dc.publisher | Informa Healthcare | en |
dc.rights.accessRights | openAccess | |
dc.subject | VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Rheumatology: 759 | en |
dc.subject | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Reumatologi: 759 | en |
dc.title | CRP as a marker for myocardial infarction and for damage accrual in systemic lupus erythematosus patients: results from a single-centre longitudinal study | en |
dc.type | Journal article | en |
dc.type | Tidsskriftartikkel | en |
dc.type | Peer reviewed | en |